PT. Dataindo Inti Swakarsa

          PT. Dataindo Inti Swakarsa
Membership | FAQ | About | Contact | Home 

Indonesia Companies - Indonesia Industry Reports - Indonesia Trade Reports - Indonesia Bilateral Reports
SEARCH  
MEMBER LOGIN    

Products

Latest Updates

Related Reports
Company News
Newly-appointed Officials
Bisnis Indonesia, page T5, 2007-07-10
PT Bio Farma has recently appointed its new board of directors for the period of 2007 to 2012. Eighty percent of the members are employees of the vaccine company. Among the newly appointed were: Isa Mansur (President Director), Rusdi Rosman (Director of Finance), Sarimuddin (Director of Marketing), Mahendra Suhardono (Director of Production) and Iskandar (Director of Planning & Development).
H5N1 Vaccine Production Awaits MoU
Bisnis Indonesia, page T7, 2006-04-12
PT Bio Farma still awaits for signed MoU between the Health Minister and the foreign company appointed to manufacture avian influenza vaccine, H5N1. Despite speculation that US-based research company Baxxter is soon to be Bio Farma’s partner, Bio Farma stated that it still do not known which company will be partnered with it.
 
Bio Farma, PT (Persero)
Indonesia Company Report
Last Update 1-October-2024
Major Businessline : Vaccine and antisera, Diagnostic

PT. Dataindo Inti Swakarsa
3rd Floor, Gapura Raya Building
Jl. Bangka Raya No. 4, Pela Mampang Email : info@disb2b.com
Jakarta 12720, Indonesia
Selective Member’s Information US $ Select All
Address 0.66
Telephone number(s) [1] 0.22
Facsimile number(s) [1] 0.44
Email 0.50
Website 0.28
Personnel (Commissioner [5], Director [6]) 6.05
Establishment Date 0.77
Tax Number (NPWP) 0.77
Business Activity 0.44
Legality (Ownership Type) 0.39
Number of employees [22-Feb-10] 0.77
Authorised Capital 3.85
Paid Up Capital 3.85
Banker(s) [1] [22-Feb-10] 0.77
Shareholder(s) [1] 3.30
Number Of Shares 3.30
Share Nominal Value 3.30
Additional Information [25-Sep-15] 0.88
Profit and Loss [2017,2018,2019,2020,2021]
(Net Sales, Cost of Goods Sold, Gross Profit, Operating Expense, Operating Profit (Loss), Other Income (Expense), Profit (Loss) After Tax, Growth)
Balance Sheet [2017,2018,2019,2020,2021]
(Total Assets, Current Assets, Non Current Assets, Other Assets, Total Liabilities, Current Liabilities, Long Term Liabilities, Minority, Shareholder's Equity)
 33.00
Ratios (Times) & Per Share Data [2017,2018,2019,2020,2021]
(PER, PBV, Current Ratio, Debt to Equity, Leverage, Gross Profit Margin, Operating Profit Margin, Net Profit Margin, Inventory Turnover, Total Assets Turnover, ROI, ROE)		 0.77
News
Bio Farma Will Produce Avian Flu Vaccination 0.39
Bio Farma Prepares 66.2 Million Dosages of Polio Vaccine 0.39
TOTAL PRICE (US$)(RP)
Price 100.001.650.000
Payment Method
Credit Card
Bank Transfer in US$
Bank Transfer in RP
Buy Now

 
Selective Member`s Discount Price
US$
To become a Selective Member
Register
Report Content
PROFIT AND LOSS 2020 2021 2022
Revenue 13,613,840 13,229,085 15,397,484
Cost of Goods N/A N/A N/A
Gross Profit 13,613,840 13,229,085 15,397,484
Net Profit Before Tax 3,139,711 4,528,733 5,123,618
The data above is sample data only
Balance Sheet (In RP Millions) 2020 2021 2022
Total Assets 133,260,087 149,168,842 150,180,752
Non Current Assets 1,888,511 1,935,151 2,024,748
Other Assets 2,885,953 4,075,426 50,103,265
Cash on Hand in Bank 47,751,808 43,551,174 27,213,874
Placement in other Bank 3,697,885 2,558,909 7,344,934
Notes & Securities 48,516,569 57,691,639 10,714,256
Loans 28,329,341 39,280,369 52,778,750
Total Liabilities 120,634,642 135,243,441 134,333,598
Cash
Minority 776 990 1,268
Total Deposits 118,251,011 131,985,222 129,555,406
Call Money 796,988 672,224 720,321
Notes Issued 252,202 425,039 652,439
Borrowings 219,652 484,127 525,316
Other Liabilities 1,114,013 1,675,839 2,878,848
Shareholder"s Equity 12,625,445 13,925,401 15,847,154
The data above is sample data only